https://www.dextrainternational.com/wp-content/uploads/2022/04/1854625464_1eb3c2a52d_b.jpg
701
1023
Sandra Módenes
http://www.dextrainternational.com/wp-content/uploads/2016/07/Logo-Dextra-300px-New.png
Sandra Módenes2021-09-22 11:50:402022-04-28 11:47:22Extension of the approval periods of the active substances 2-phenylphenol, 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuronPosts
https://www.dextrainternational.com/wp-content/uploads/2022/04/1854625464_1eb3c2a52d_b.jpg
701
1023
Sandra Módenes
http://www.dextrainternational.com/wp-content/uploads/2016/07/Logo-Dextra-300px-New.png
Sandra Módenes2021-09-22 11:50:402022-04-28 11:47:22Extension of the approval periods of the active substances 2-phenylphenol, 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
Amendement of the conditions of approval of the active substance prosulfuron
COMMISSION IMPLEMENTING REGULATION (EU) 2021/574
of 30 March 2021
amending Implementing Regulations (EU) 2017/375 and (EU) No 540/2011 as regards the conditions of approval of the active substance prosulfuron
(Text with EEA relevance)
THE…

Approval of the low-risk active substance aqueous extract from the germinated seeds of sweet Lupinus albus
COMMISSION IMPLEMENTING REGULATION (EU) 2021/567
of 6 April 2021
approving the low-risk active substance aqueous extract from the germinated seeds of sweet Lupinus albus in accordance with Regulation (EC) No 1107/2009 of the European Parliament…

Amendment of the conditions of approval of the active substance fenpyrazamine
COMMISSION IMPLEMENTING REGULATION (EU) 2021/459
of 16 March 2021
amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance fenpyrazamine
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having…

Non-approval of carbon dioxide as a basic substance
COMMISSION IMPLEMENTING REGULATION (EU) 2021/80
of 27 January 2021
concerning the non-approval of carbon dioxide as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning…

Renewal of the approval of the low-risk active substance Akanthomyces muscarius strain Ve6 (formerly Lecanicillium muscarium strain Ve6)
COMMISSION IMPLEMENTING REGULATION (EU) 2021/134
of 4 February 2021
renewing the approval of the low-risk active substance Akanthomyces muscarius strain Ve6 (formerly Lecanicillium muscarium strain Ve6) in accordance with Regulation…

New European Union MRLs for chlorpyrifos and chlorpyrifos-methyl
The new MRLs for chlorpyrifos and chlorpyrifos-methyl were announced on 11 August 2020 and entered into force on 13 November 2020 (Regulation (EC) 2020/1085 and Corrigendum); this means that they can no longer be used after this date.
Operators…

Extension of approval periods for some active substances
COMMISSION IMPLEMENTING REGULATION (EU) 2020/1511
of 16 October 2020
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine,…

Non-renewal of approval of the active substance thiophanate-methyl
COMMISSION IMPLEMENTING REGULATION (EU) 2020/1498
of 15 October 2020
concerning the non-renewal of approval of the active substance thiophanate-methyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council…
HQ EUROPE
Avenida Diagonal 468, 6th Floor
Barcelona | 08006, Barcelona, Spain
HQ USA
1395 Brickell Avenue, Suite 800 & 900
Miami | FL 33131 USA
HQ LATAM
Calle 24 #95 - A No. 80 - Of. 517
Edificio Colfecar | Bogotá, Colombia
HQ ASIA
Of. 406, Block B, 4/F Mirror Tower, 61 Mody Road
Tsim Sha Tsui East | Hong Kong
